Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S P Taback

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Diabetes Care|June 27, 2000
Controlled trials of HbA1c measurementsS P Taback
Diabetes Care|July 27, 2001
The effect of day care exposure on the risk of developing type 1 diabetes: a meta-analysis of case-control studiesB Kaila, S P Taback
The Journal of Clinical Endocrinology and Metabolism|May 1, 1996
Mortality in Canadian children with growth hormone (GH) deficiency receiving GH therapy 1967-1992. The Canadian Growth Hormone Advisory CommitteeS P Taback, H J Dean
The New England Journal of Medicine|May 22, 1997
Turner's syndromeS P Taback, C Deal, G Van Vliet
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|May 26, 1999
Pharmacological manipulation of height: qualitative review of study populations and designsS P Taback, H J Guyda, G Van Vliet
Diabetic Medicine : a Journal of the British Diabetic Association|August 20, 2003
HLA, day care attendance, and socio-economic status in young patients with Type 1 diabetesB Kaila, H J Dean, M Schroeder, et al.
The Cochrane Database of Systematic Reviews|October 21, 2004
Force platform feedback for standing balance training after strokeR Barclay-Goddard, T Stevenson, W Poluha, et al.
Lancet (London, England)|July 6, 1996
Does growth-hormone supplementation affect adult height in Turner's syndrome?S P Taback, R Collu, C L Deal, et al.
The Cochrane Database of Systematic Reviews|July 22, 2004
Hepatitis B vaccination for patients with chronic renal failureR J Schroth, C A Hitchon, J Uhanova, et al.
Journal of Medical Genetics|July 15, 2005
Type 1 diabetes and the OAS gene cluster: association with splicing polymorphism or haplotype?M-C Tessier, H-Q Qu, R Fréchette, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Diabetes Care|June 27, 2000
Controlled trials of HbA1c measurementsS P Taback
Diabetes Care|July 27, 2001
The effect of day care exposure on the risk of developing type 1 diabetes: a meta-analysis of case-control studiesB Kaila, S P Taback
The Journal of Clinical Endocrinology and Metabolism|May 1, 1996
Mortality in Canadian children with growth hormone (GH) deficiency receiving GH therapy 1967-1992. The Canadian Growth Hormone Advisory CommitteeS P Taback, H J Dean
The New England Journal of Medicine|May 22, 1997
Turner's syndromeS P Taback, C Deal, G Van Vliet
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|May 26, 1999
Pharmacological manipulation of height: qualitative review of study populations and designsS P Taback, H J Guyda, G Van Vliet
Diabetic Medicine : a Journal of the British Diabetic Association|August 20, 2003
HLA, day care attendance, and socio-economic status in young patients with Type 1 diabetesB Kaila, H J Dean, M Schroeder, et al.
The Cochrane Database of Systematic Reviews|October 21, 2004
Force platform feedback for standing balance training after strokeR Barclay-Goddard, T Stevenson, W Poluha, et al.
Lancet (London, England)|July 6, 1996
Does growth-hormone supplementation affect adult height in Turner's syndrome?S P Taback, R Collu, C L Deal, et al.
The Cochrane Database of Systematic Reviews|July 22, 2004
Hepatitis B vaccination for patients with chronic renal failureR J Schroth, C A Hitchon, J Uhanova, et al.
Journal of Medical Genetics|July 15, 2005
Type 1 diabetes and the OAS gene cluster: association with splicing polymorphism or haplotype?M-C Tessier, H-Q Qu, R Fréchette, et al.
Pageof 1